Clinical Trials
6
Active:0
Completed:3
Trial Phases
1 Phases
Phase 3:6
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Phase 3
6 (100.0%)Standard Clopidogrel Versus Prasugrel Low Dose Therapy in Elderly Patients With Acute Coronary Syndrome
- First Posted Date
- 2013-01-29
- Last Posted Date
- 2013-01-29
- Lead Sponsor
- Gennaro Sardella
- Target Recruit Count
- 68
- Registration Number
- NCT01778842
- Locations
- 🇮🇹
Dept.of Cardiovascular Sciences,Policlinico Umberto I, Rome, Italy
PraSugrel vs TicagrElor in ST-Elevation Myocardial Infarction paTients With Diabetes Mellitus
Phase 3
Completed
- Conditions
- ST-Elevation Myocardial Infarction
- Interventions
- First Posted Date
- 2012-02-10
- Last Posted Date
- 2017-06-28
- Lead Sponsor
- Gennaro Sardella
- Target Recruit Count
- 50
- Registration Number
- NCT01531114
- Locations
- 🇮🇹
Dept.of Cardiovascular Sciences,Policlinico Umberto I, Rome, Italy
Impact of Different Treatment in Multivessel Non ST Elevation Myocardial Infarction (NSTEMI) Patients: One Stage Versus Multistaged Percutaneous Coronary Intervention (PCI)
Phase 3
- Conditions
- Non ST Segment Elevation MI and Unstable Angina
- First Posted Date
- 2011-11-24
- Last Posted Date
- 2011-11-24
- Lead Sponsor
- Gennaro Sardella
- Target Recruit Count
- 247
- Registration Number
- NCT01478984
- Locations
- 🇮🇹
Dept.of Cardiovascular Sciences,Policlinico Umberto I, Rome, Italy
Therapy With High Clopidogrel Dose or Prasugrel Standard Dose Reduces the Platelet Reactivity in Patients With Genotype Variation RESET GENE Trial
- First Posted Date
- 2011-11-06
- Last Posted Date
- 2012-03-27
- Lead Sponsor
- Gennaro Sardella
- Target Recruit Count
- 30
- Registration Number
- NCT01465828
- Locations
- 🇮🇹
Dept.of Cardiovascular Sciences,Policlinico Umberto I, Rome, Italy
ROsuvastatin Pretreatment to Reduce MyocArdial Periprocedural Necrosis:Comparison With Atorvastatin Reloading
Phase 3
Completed
- Conditions
- Assess the Periprocedural Myocardial Necrosis
- Interventions
- First Posted Date
- 2010-10-26
- Last Posted Date
- 2013-01-04
- Lead Sponsor
- Gennaro Sardella
- Target Recruit Count
- 310
- Registration Number
- NCT01228227
- Locations
- 🇮🇹
Policlinico Umberto I, Roma, Italy
- Prev
- 1
- 2
- Next
News
No news found